Axplora

Live from CPHI Middle East! Farmabios, an Axplora company, is proudly represented by Massimiliano Andreoli and Tommaso Landolfi, who will be actively engaging with industry peers and partners throughout the event. 🌟 Axplora’s Italian facility is our center of excellence for steroid API manufacturing and is world renowned for its expertise in HPAPIs and cytotoxic compounds. With a team of 270 dedicated professionals, the site produces over 80 APIs, supported by a library of 700+ compounds and a proven synthesis route. It also offers cutting-edge services, including sterilization via filtration—one of the few facilities in the world with this capability! This summer, it was also awarded the prestigious EcoVadis Platinum Score, placing it in the top 1% of companies evaluated! 🏆 Connect with our team to explore how Axplora is driving innovation in pharmaceutical manufacturing. #Axplora #Farmabios #CPHIMiddleEast

♻️ Axplora’s EcoVadis certification in Raubling (Germany) is another milestone in our journey toward Environmental, Social, and Governance (ESG) excellence. Ranked among the top tertile organizations, the recognition underscores our dedication to sustainable and responsible operations. 🏅 ✔️ This year, we made significant strides in sustainable procurement by reinforcing our existing partnerships with quality suppliers who share our high standards for compliance, ethics, and sustainability, driving substantial improvements across our value chain. This achievement fuels our ambition to raise the bar—enhancing transparency, driving impactful initiatives, embracing green innovations, and delivering meaningful benefits for people and the planet. 🌍 Congratulations to all the teams who made this possible! 👏 #EcoVadis #ESG #Sustainability

This Thanksgiving, we’re celebrating the spirit of collaboration and the sense of family we share with our valued partners, clients, and colleagues across the United States. 🇺🇸 Together, as one united family, we’re breaking boundaries in pharmaceutical manufacturing—pioneering advancements in GLP-1s, ADCs, and complex APIs. At Axplora, we redefine what’s possible, delivering reliable solutions that ensure life-changing treatments reach patients #faster. From our Axplora family to yours, Happy Thanksgiving! 🍂🍁 #Thanksgiving

🏃♀️🏃♂️ Congratulations to our 15-strong team from Axplora’s Le Mans (France) site for completing the 10km Maine Libre race, named after the region’s daily newspaper! 🚀 This success isn’t just about crossing the finish line; it's about the relentless drive, teamwork, and speed to exceed expectations. At Axplora, we build on this mindset to deliver reliable solutions #faster, reducing the drug development cycle and pushing the limits of speed-to-market. We rise to the challenge—and go beyond it—making a real impact on patients' lives worldwide. 🌐 #AxploraTeam #SpeedToMarket #Teamwork #PharmaceuticalManufacturing

At Axplora, our apprentices don’t just learn—they inspire us. Their fresh ideas and vibrant energy bring new perspectives to our teams, enriching the diversity of our skilled workforce and helping us push the boundaries of API manufacturing to get medicines to market #faster. 🚀🚀 🙌🙌 We are especially proud of Alessia Ochs and Mert Salih Ayyildiz from our Leverkusen facility, who have been recognized by the German Chamber of Commerce (IHK Köln) for their « outstanding achievements in vocational training ». With almost 100 apprentices across Axplora locations, we’re building the future together—one idea, one achievement, and one bold step at a time. 🌟 #Axplora #Apprentices #Leverkusen

🌟 At Axplora, we deliver better outcomes by continuously improving our processes, enabling faster delivery of life-changing medicines to market and patients worldwide. Last week, a 20-strong team from Research & Development, Quality Control and Regulatory Affairs trained on analytical development under ICH Q14 guidelines, reinforcing our ability to develop robust, efficient and reliable methods to ensure the consistent quality our customers depend on. The ICH Q14 framework promotes flexibility and innovation through science and risk-based approaches. By integrating Quality by Design (QbD) and Design of Experiments (DoE) principles, we’re accelerating the manufacturing of the medicines that matter most. 👇 Explore the below for a closer look at the tools we use! 👇 #ICHQ14 #ContinuousImprovement #Pharma #Biotech

🌍 This year, the conversation at Jefferies Healthcare Conference centers around some of the most pressing industry trends: the unprecedented growth in both GLP-1s and ADCs, how fast they can get to market, and the associated manufacturing challenges, including reshoring. 🔬 As your trusted partner, we’re ready to transform these challenges into opportunities. Our manufacturing network ensures speed and reliability, while our expertise in #GLP-1s and #ADCs helps bring life-changing therapies to market faster than ever. 🤝 Let’s explore the future of medicine manufacturing together. Connect with our CEO Martin Meeson and our CCO Arul Ramadurai at #JefferiesHealthcare Conference in London until Thursday! #Axplora #JefferiesHealthcare #ReliablePartner #AgileExplorer

🌟 From the skyrocketing growth in GLP-1s and ADCs to conquering the most intricate manufacturing challenges, the future of medicine demands unmatched speed, agility, and regulatory strength—to deliver life-changing treatments to patients faster than ever. 🚀 Discover how our agile partnerships transform your toughest challenges into opportunities for speed, rock-solid reliability, and extraordinary success. Join us at the Pharma Manufacturing & Outsourcing Summit in Boston (MA) later today! 🗣️ Arul Ramadurai ~ Group Chief Commercial Officer ● Serge Kechichian ~ Head of Sales & Business Development, North America #USPharma24 #GLP-1 #ADC

Last week, we were honored to welcome Valérie Hayer (Member of the European Parliament) to our Le Mans (France) site. Her visit followed our recent investment to expand capacity for antibody drug conjugate (#ADC) payload manufacturing, supported by #France2030 program. As our center of excellence for ADC payloads and bioconjugation, Le Mans brings over 35 years of experience in HPAPI synthesis and purification, and plays a key role in the supply chain of 6 out of the 13 commercial ADCs on the market. 👩🔬👨🔬 Over 150 dedicated employees in Le Mans continue to push the boundaries of pharmaceutical innovation by delivering life-changing treatments to cancer patients worldwide. #Axplora #France2030 #FranceChimie #SICOS #EFCG

Are you looking for optimal particle size control of your API?   Obtaining the required particle size control is crucial in API manufacturing, affecting solubility, bioavailability, stability and therefore the drug's overall performance. 🎯   At Axplora, we carry out wet milling at development and production scales, with real-time particle size distribution (PSD) monitoring via Mettler-Toledo International, Inc’s EasyViewer™.   Our experts are well-equipped to help our customers get the desired API grade/s while ensuring seamless scale-up and consistent quality from lab to industrial production: — Best-in-class design and optimization of crystallization and griding conditions including solvents, temperature and duration — Achieving consistent PSD values to meet stringent API specifications — Reduction of production time up to 20% by avoiding solid isolations and need for additional dry milling step; with the subsequent cost improvement — Improved occupational safety by minimization of solid handling   💬 Contact us and talk to our technical team!   By investing in technologies like wet milling, Axplora continues to set new standards in API manufacturing, meeting the diverse needs of our customers worldwide.   #Axplora #WetMilling #API #ParticleSize